ADVANZ Pharma (formerly Concordia)

About ADVANZ Pharma

ADVANZ Pharma, formerly known as Concordia, is a global pharmaceutical company headquartered in the UK. The company is dedicated to providing high-quality medicines that improve patient outcomes and enhance the quality of life. With a strong focus on specialty pharmaceuticals, ADVANZ Pharma develops, manufactures, and markets a diverse portfolio of products across various therapeutic areas.

Our mission is to deliver innovative solutions that address unmet medical needs while ensuring accessibility for patients worldwide. We pride ourselves on our commitment to quality, compliance, and sustainability in all aspects of our operations.

ADVANZ Pharma’s core activities include:

• Research and Development: Investing in cutting-edge research to develop new therapies.
• Manufacturing: Utilizing state-of-the-art facilities to produce high-quality pharmaceuticals.
• Marketing and Distribution: Ensuring our products reach healthcare providers and patients efficiently.

We believe in fostering strong partnerships with healthcare professionals, patients, and stakeholders to drive innovation and improve health outcomes. Our team of experts is dedicated to advancing healthcare through collaboration and knowledge sharing.

As we continue to grow, ADVANZ Pharma remains committed to our vision of becoming a leader in the specialty pharmaceuticals sector, making a positive impact on global health.